Biofrontera Inc.(BFRI)

Medical - Pharmaceuticals · Woburn, MA

$0.93+0.04 (+4.61%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T22:11:06.697Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:11:06.697Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 11,932,717
Total debt · period ending 2026-06-30: 7,504,000
Cash · period ending 2026-06-30: 4,659,000
TTM operating income · period ending 2026-06-30: -4,364,000

FMP input reference: b47096c20191003074eea3dc75a1498d2bed5743fa2797f84e024bc92f81a74c

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BFRI EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

BFRI Competitors' EV/EBIT Ratio

BFRI

Biofrontera Inc.

Current

Market Cap

$11.93M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLRB

Cellectar Biosciences, Inc.

vs BFRI

Market Cap

$12.06M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRIX

IRIDEX Corporation

vs BFRI

Market Cap

$11.77M

EV/EBIT Ratio

N/A

TTM Avg

1095.87x

3Y Avg

388.61x

5Y Avg

279.45x

LTRN

Lantern Pharma Inc.

vs BFRI

Market Cap

$12.17M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHIO

Phio Pharmaceuticals Corp.

vs BFRI

Market Cap

$11.55M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTSO

Cytosorbents Corporation

vs BFRI

Market Cap

$12.44M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DARE

Dare Bioscience, Inc.

vs BFRI

Market Cap

$12.48M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs BFRI

Market Cap

$11.36M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TPST

Tempest Therapeutics, Inc.

vs BFRI

Market Cap

$12.58M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VTGN

VistaGen Therapeutics, Inc.

vs BFRI

Market Cap

$11.12M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Biofrontera Inc. (BFRI)	$11.93M	N/A	N/A	N/A	N/A
Cellectar Biosciences, Inc. (CLRB)vs ›	$12.06M	N/A	N/A	N/A	N/A
IRIDEX Corporation (IRIX)vs ›	$11.77M	N/A	1095.87x	388.61x	279.45x
Lantern Pharma Inc. (LTRN)vs ›	$12.17M	N/A	N/A	N/A	N/A
Phio Pharmaceuticals Corp. (PHIO)vs ›	$11.55M	N/A	N/A	N/A	N/A
Cytosorbents Corporation (CTSO)vs ›	$12.44M	N/A	N/A	N/A	N/A
Dare Bioscience, Inc. (DARE)vs ›	$12.48M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$11.36M	N/A	N/A	N/A	N/A
Tempest Therapeutics, Inc. (TPST)vs ›	$12.58M	N/A	N/A	N/A	N/A
VistaGen Therapeutics, Inc. (VTGN)vs ›	$11.12M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

BFRI EV/EBIT Ratio Metrics

BFRI Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics